Moderna, Merck cancer combo cuts melanoma spread risk at five years

May 21 () - Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another ‌part ...
AOL

Promising vaccine for aggressive melanoma could unlock the body’s potential to fight cancer

An experimental skin cancer vaccine developed by pharmaceutical companies Moderna and Merck shows promising results after a five-year follow-up in clinical trials. The findings point to strong, ...
Hosted on MSN

Experimental Nanoparticle “Super-Vaccines” Stop Breast, Pancreatic, And Skin Cancers In Their Tracks

A nanoparticle vaccine has shown great promise in preventing three types of cancer in mice, as well as stopping tumors from spreading when they were exposed to cancerous cells. Cancer vaccines have ...
Reuters

IO Biotech's cancer vaccine shows improvement, but narrowly misses study goal

Aug 11 (Reuters) - IO Biotech (IOBT.O), opens new tab said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's progression in a late-stage study, but ...
AOL

Moderna, Merck's skin cancer vaccine shows sustained benefit after five years

FILE PHOTO: Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Jan 20 (Reuters) - Moderna and ...
Wane

Merck, Moderna detail potential skin cancer vaccine progress

Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer. The company said a possible melanoma vaccine it is ...